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Wnt signaling represents a highly versatile signaling
system, which plays diverse and critical roles in
various aspects of neural development. Sensory
neurons of the dorsal root ganglia require Wnt
signaling for initial cell-fate determination as well as
patterning and synapse formation. Here we report
that Wnt signaling pathways persist in adult sensory
neurons and play a functional role in their sensitiza-
tion in a pathophysiological context. We observed
that Wnt3a recruits the Wnt-calcium signaling
pathway and the Wnt planar cell polarity pathway in
peripheral nerves to alter pain sensitivity in a modal-
ity-specific manner and we elucidated underlying
mechanisms. In contrast, biochemical, pharmaco-
logical, and genetic studies revealed lack of func-
tional relevance for the classical canonical b-catenin
pathway in peripheral sensory neurons in acute
modulation of nociception. Finally, this study pro-
vides proof-of-concept for a translational potential
for Wnt3a-Frizzled3 signaling in alleviating disease-
related pain hypersensitivity in cancer-associated
pain in vivo.
INTRODUCTION
Wnt proteins are important, evolutionarily conserved mediators
of cell-cell communication that govern cell fate and patterning
over development (Patapoutian and Reichardt, 2000; Grigoryan
et al., 2008). During sensory development, Wnt signaling has
been described as a major regulator of early lineage specificity
as well as later differentiation and patterning of neurotrophin-3-
positive sensory axons of the dorsal root ganglia (DRG) and
development of their contacts with motoneurons in the spinal
cord (Patapoutian and Reichardt, 2000; Budnik and Salinas,
2011). Furthermore, Wnt signaling in adult organisms modulates104 Neuron 83, 104–121, July 2, 2014 ª2014 Elsevier Inc.tissue regeneration and homeostasis in several organs as well as
plasticity and disease pathophysiology in the adult CNS (Yuan
et al., 2012; Grigoryan et al., 2008; MacDonald et al., 2009).
The Wnt proteins are family of 19 highly conserved glycopro-
teins that are glycosylated and palmitoylated prior to tightly regu-
lated secretion into the extracellular milieu (Komiya and Habas,
2008;MacDonald et al., 2009). Wnts can activate the intracellular
canonical or b-catenin-dependent pathway, which involves
b-catenin-mediated gene regulation, as well as several nonca-
nonical or b-catenin-independent signal transduction cascades,
all via activation of cell-surface G protein-coupled receptors
(GPCRs) called Frizzleds (Fzds) (Komiya and Habas, 2008). In
addition, Wnt signaling pathways can involve coreceptors in a
context-dependent manner, such as the low-density lipopro-
tein-related protein 5 and 6 (LRP5 and LRP6), as well atypical
receptor tyrosine kinases, such as Ryk or Ror (Komiya and
Habas, 2008; MacDonald et al., 2009).
Here we report that this classical developmental signaling
system is also active in adult sensory nerves and modulates
sensitivity to nociceptive stimuli and we elucidate the underlying
molecular mechanisms and contributions of diverse canonical
and noncanonical pathways. Moreover, we provide proof-of-
concept for a therapeutic relevance for interfering with Fzd1/3
signaling in alleviating nociceptive hypersensitivity in models of
cancer pain in vivo.RESULTS
Expression of Wnt Signaling Mediators in Adult
Peripheral Sensory Neurons
RT-PCR analysis as well as direct RNA sequencing revealed that
a majority of components of the Wnt signaling system are
expressed in lumbar DRG of adult wild-type mice (Figure 1A;
Table S1 available online); these included diverse Fzds (Fzd1
and Fzd3 being most prominent), coreceptors such as LRP5,
LRP6, Ryk, and Ror2, as well as signaling proteins, such as
Dishevelled isoforms 1–3 (Dvl1, Dvl2, and Dvl3) and b-catenin,
indicating representation of both canonical as well as noncanon-
ical branches of Wnt signaling.
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Fzd1 and anti-Fzd3 was observed in neurons costained with the
neuronal marker, b-tubulin III; coincubation of the corresponding
epitope peptides led to loss of staining upon (Figure 1B). Cos-
taining with marker proteins revealed that 18% of Isolectin-B4-
positive (IB4+ve) nociceptive neurons, 21% of small diameter
peptidergic nociceptive neurons express Fzd1, and 42%
of NF-200-positive large-diameter (nonnociceptive) neurons
express Fzd1 (Figures 1C and 1E). In contrast, anti-Fzd3 immu-
noreactivity was found in about 40% of small diameter Isolectin-
B4-positive nociceptive neurons, about 60% of peptidergic
nociceptive neurons, and in about 72% of NF-200-positive neu-
rons (Figures 1D and 1E). Heterozygous BAC transgenic mice
expressing GFP in the Fzd3 locus verified the specificity of the
Fzd3 antibody and further confirmed the expression profile of
Fzd3 sensory neurons in adult mouse DRG (Figure 1F). Further-
more, both Fzd3-GFP mice and the Fzd3 antibody revealed that
Fzd3 is targeted to peripheral nerves that are PGP9.5-immuno-
reactive in the paw skin (Figure 1F).
Functional Impact of Activation of Peripheral Wnt
Receptors on Pain Sensitivity
To address the functional significance of potential Wnt3a-Fzd1/
3-mediated interactions between peripheral tissues and sensory
nerves, we applied recombinant Wnt3a or the vehicle (PBS) via
intraplantar injection to the hindpaw of naive wild-type mice.
Wnt3a-injected animals did not show any signs of spontaneous
pain; however, upon plantar application of graded mechanical
stimuli (von Frey hairs) to the surface of the injected paw, the fre-
quency of paw withdrawal responses to mechanical stimuli
increased in Wnt3a-treated mice, in contrast to vehicle-treated
mice (Figure 2A). Treatment with Wnt3a also led to a dose-
dependent decrease in the latency of paw withdrawal in
response to infrared heat in the plantar test (Figure 2B), indi-
cating thermal hyperalgesia. Both mechanical and thermal
hypersensitivity induced by Wnt3a were dose dependent, with
doses as low as 100 pg eliciting significant behavioral changes
(Figures 2A–2D), but showed highly divergent onset and peak
periods after Wnt application (Figures 2C and 2D).
In all of the ensuing pharmacological experiments throughout
this study in which Wnt3a-mediated thermal hyperalgesia was
tested at 7 hr postinjection, inhibitors of pathways were given
continuously over the entire period up to 7 hr after Wnt delivery.
Intraplantar pretreatment with NSC668036, a compound that
specifically inhibits Dishevelled and thereby abolishes Wnt-
mediated signaling (Shan et al., 2005), completely blocked
Wnt3a-mediated thermal as well as mechanical hypersensitivity
(Figures 2E and 2F), indicating specific, receptor-mediated func-
tions (Figures 2E and 2F). Furthermore, intraplantar injection of
neutralizing, function-blocking antibodies against Fzd1 and
Fzd3 completely inhibited Wnt3a-induced mechanical hyper-
sensitivity (Figure 2E) but only partially blocked Wnt3a-induced
thermal hyperalgesia (Figure 2F), suggesting a contribution of
other Fzds or coreceptors.
We utilized a perfused skin-nerve preparation from the mouse
hindpaw and performed electrophysiological recordings on
single A-delta mechanoceptor fibers in the saphenous nerve in
response to graded mechanical stimulation of the innervationterritory in the skin (Koltzenburg et al., 1997) (Figure 2G). In
contrast to treatment with vehicle, application of Wnt3a to the
innervated skin led to a dose-dependent potentiation of nerve
responses within 30 min (average responses shown Figure 2H),
thereby suggesting that Wnt3a can directly sensitize peripheral
sensory nerves. As compared to vehicle, 69% of fibers tested
showed more than 20% increase in their response magnitudes,
and the remaining 31% did not sensitize (Figure 2I), indicating
that only a subpopulation of nociceptors are responsive to
Wnt3a.
Minor Contribution of the Canonical Pathway
to Wnt3a-Induced Pain Hypersensitivity
To understand themechanisms, we first addressed the contribu-
tion of the classical Wnt canonical b-catenin pathway in sensory
neurons, which is one of the best understood of all Wnt signaling
pathways (Grigoryan et al., 2008) (Figure 3A). Briefly, interaction
of Wnt ligands with Fzd receptors and its coreceptor Lrp6 re-
cruits Dishevelled, induces phosphorylation of Lrp6, and further
recruits the Axin complex to the activated receptor, leading to
inhibition of b-catenin phosphorylation and thereby to the accu-
mulation of cytosolic b-catenin (Figure 3A). b-catenin then travels
to the nucleus to form complexes with TCF/LEF-family transcrip-
tional factors and thereby activate Wnt-target gene expression
(MacDonald et al., 2009). By employing three complementary
approaches, we observed that Wnt3a stimulates the activation
of the canonical pathway in a fraction of DRG neurons. First, in
neuron-enriched cultures of mouse DRG, Wnt3a-treatment led
to a small, but significant, upregulation of Axin2 and Dkk1 tran-
scripts, which are classical b-catenin transcriptional targets
(Glinka et al., 1998) (Figure 3B). Second, immunocytochemistry
on cultured DRG neurons revealed that 5% ± 1% of DRG
neurons demonstrated a Wnt3a-induced nuclear translocation
of b-catenin (Figure 3C), which increased to 20% ± 4% cells
when nonneuronal cells were allowed to grow in DRG cultures,
suggesting that the canonical pathway may be operational to a
more significant extent in nonneuronal cells than in neurons
in adult DRG. Finally, in a reporter mouse line in which b-galac-
tosidase expression is driven by activated b-catenin and
TCF signaling in vivo (BAT-GAL mice; Maretto et al., 2003),
1% ± 0.3% and 7% ± 1% of DRG neurons showed b-galactosi-
dase activity at 24 hr after intraplantar injection of PBS or Wnt3a,
respectively (Figure 3D). Consistent with the reported inhibition
of canonical Wnt signaling by noncanonical signaling, in partic-
ular via pathways downstream of Ca2+/calmodulin-dependent
protein kinase II (CaMKII) activation (Ishitani et al., 2003),
25% ± 5% of DRG neurons showed b-galactosidase activity
when we treated mice with intraplantar Wnt3a in the presence
of a CaMKIIa inhibitor, KN-93 (Figure 3D). Thus, in DRG neurons,
Wnt3a-induced activation of canonical pathway is held in check
by concurrent activation of noncanonical calcium signaling
in vivo.
Modulators of Wnt signaling, such as Fumagillin and Dkk1
(Niehrs, 2006), differentially modulated Wnt3a-induced mechan-
ical hypersensitivity and thermal hyperalgesia (Figure S1).
However, because neither Fumagillin nor Dkk1 modify canonical
or noncanonical Wnt signaling exclusively, we generated
mice lacking b-catenin either in a nociceptor-specific mannerNeuron 83, 104–121, July 2, 2014 ª2014 Elsevier Inc. 105
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Wnt Signaling in Sensory Neurons and Pain(SNS-b-catenin/ mice; Figures 3E and 3F) generated using
SNS-Cre mice (Agarwal et al., 2004) or lacking b-catenin in all
cells of the DRG (Adv-b-catenin/mice), generated using Advil-
lin-Cre mice (Zurborg et al., 2011) (see scheme of generation
and characterization of transgenic mice in Figure S2A). Immuno-
histochemical analysis confirmed a lack of b-catenin expression
in small-diameter neurons in SNS-b-catenin/ mice and in all
DRG neurons in Adv-b-catenin/ mice but preserved expres-
sion in satellite cells in both (Figure S2B). Wnt3a-induced Axin
upregulation was completely abolished in the DRG of Adv-
b-Catenin/ mice and partially so in SNS-b-catenin/ mice
(Figure S2C), indicating pan-DRG or nociceptor-specific func-
tional blockade of b-catenin activity, respectively. In behavioral
experiments, SNS-b-catenin/ mice, Adv-b-catenin/ mice,
and their b-cateninloxP/loxP littermates (control) showed compa-
rable magnitudes of mechanical and thermal hypersensitivity
upon intraplantar injection of Wnt3a (Figures 3E and 3F). Thus,
Wnt3a-induced sensitization was fully intact despite a lack of
b-catenin signaling in nociceptors or all DRG neurons.
Furthermore, to avoid any potential occlusion of a behavioral
phenotype owing to early postnatal loss of b-catenin expression
in the above transgenic mouse lines, we utilized recombinant
adeno-associated vectors of serotypes 1 and 2 (rAAV1/2) to
deliver Cre recombinase broadly in L3-L4 DRG following direct
intra-DRG injections in adult b-cateninloxP/loxP mice in vivo. In
other experiments, we employed a newly described, specific
modulator of canonical signaling, namely PNU-74654, which
inhibits TCF/b-catenin-mediated transcription (Durand et al.,
2011; Figure S1C). In both cases, mechanical and thermal hyper-
sensitivity evoked by intraplantar injection of Wnt3a were fully
preserved upon adult-onset loss or blockade of b-catenin in
DRG neurons, respectively (Figures 3G, 3H, and 3I). Taken
together, multiple independent lines of evidence indicate that
the contribution of neuronal canonical signaling in the DRG to
Wnt3a-induced acute nociceptive hypersensitivity in vivo is
relatively minor.
Wnt Signaling via the Noncanonical Calcium Pathway in
DRG Neurons: A Mechanistic Basis for Wnt3a-Induced
Thermal Hyperalgesia
One of the prominent Wnt noncanonical pathways involves Fzd-
Gaq/11-phospholipase C (PLC-b)-mediated release of calcium
from intracellular stores and downstream activation signaling
molecules, such as CaMKII, protein kinase C (PKC), Src, and
calcineurin, among others (Figure 4A); this pathway is develop-
mentally important, but not commonly operational in all Fzd-
expressing cells (Komiya and Habas, 2008). We treated mouse
DRG neurons cultured for a few days with Wnt3a or vehicle
and performed Fura-2-based calcium imaging. We observedFigure 1. Expression of Wnt Receptors Fzd1 and Fzd3 in Somata and
(A) RT-PCR analysis on mouse dorsal root ganglia (DRG). Negative controls: sam
expression.
(B) Immunofluorescence analysis of expression of Fzd1 and Fzd3 in neurons of the
with corresponding blocking peptides.
(C, D, and E) Immunofluorescence analysis of expression of Fzd1 (C) and Fzd3
neurons of mouse lumbar DRG and the corresponding quantification (E).
(F) Use of Fzd3-GFP reporter mice to reveal Fzd3 promoter-driven GFP expressi
bars represent 30 mm in (B) and 50 mm in (C), (D), and (F). Data represent mean ±that in contrast to vehicle, approximately 20%± 3%of DRG neu-
rons treated with Wnt3a responded acutely with slow calcium
transients of varying magnitudes, which typically reached peak
at 4 ± 2 s after Wnt3a application and had an average duration
of 55 ± 18 s. Surprisingly, approximately 39% ± 5% of neurons
responded with either a second peak of comparable magnitude
or a delayed first peak with a latency of 4–5 min after the appli-
cation of Wnt3a. To avoid confounding interpretations by growth
factors which were added during culturing, we then performed
calcium imaging on isolated DRG neurons acutely and applied
Wnt3a or vehicle in ringer solution via a continuous perfusion
so as to avoid causing any mechanical artifacts. Also under
these experimental conditions, we observed results similar to
those described above (see Figure 4B for typical examples and
a summary graph), indicating that these delayed responses are
not mechanical artifacts but probably reflect calcium triggered
by mediators that are released from sensory neurons upon
Wnt3a signaling. At 3 min after treatment with Wnt3a or vehicle
of acutely dissociated DRG neurons that were isolated in the
absence of exogenously added growth factors, ELISA-based
analysis revealed that Wnt3a-treated cultures showed a signifi-
cant increase in the concentration of 7 of 12 different cytokines
tested, including IL-2, IL-4, IL-10, IL-12, IL-17A, TNFa, and
GM-CSF (Figure 4C), several of which are known to activate
and sensitize DRG neurons.
Consistent with an activation of the noncanonical Ca2+
signaling pathway, neurons in L3/L4 DRGs of mice injected intra-
plantarly with Wnt3a in the paw showed an increase in immuno-
reactivity for pCaMKIIa at 30 min after Wnt treatment (Figure 4D)
as compared to vehicle-injected mice (Figure 4D). This was
further confirmed in western blot analysis (Figures 4E and 4F).
Similarly, amarked increase in phosphorylation of another prom-
inent target of calcium, namely Src, was observed at 30 min after
Wnt treatment over vehicle-treated mice without changing total
Src expression (Figure 4G), which could be blocked upon plantar
coinjection of either a pharmacological inhibitor of Src, namely
PP2 (Figure S3A), or of an anti-Fzd3 antibody (Figure 4G). Treat-
ment with PP2 or anti-Fzd3 antibody alone did not affect levels of
phosphorylated Src (Figure S3).
Both Src and CamKIIa have been associated functionally with
sensitization of TRPV1 in sensory neurons and TRPV1 has been
shown to be a key mediator of heat hypersensitivity in a wide set
of animal models of pain (Zhang et al., 2005, Basbaum et al.,
2009). Therefore, we performed several experiments on DRG
neurons in vitro and in vivo to determine whether exposure of
DRG neurons to Wnt3a quantitatively impacts on the level of
expression and surface localization of TRPV1 and characterized
the corresponding time course. We utilized a commercial anti-
body directed against TRPV1 as well as a highly specificAxons of Peripheral Sensory Neurons
ples without reverse transcriptase (RT) and water (W); positive control: Ga12
lumbar DRG, identified via staining for b-tubulin III (b-TubIII), including controls
(D) in peptidergic (CGRP-positive) and nonpeptidergic (Isolectin-B4 binding)
on in sensory and in axons in the paw skin (colocalization with PGP9.5). Scale
SEM. Also see Tables S1 and S5.
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Figure 2. Activation of Wnt3a Receptors in the Skin Leads to Nociceptive Sensitization
(A and B) Characterization and dose-response relationships of the effects of recombinant mouse Wnt3a or of vehicle following a single intraplantar injection in
mouse hindpaw on sensitivity to graded mechanical von Frey stimuli (A; expressed as response frequency to five applications/von Frey filament) measured at
30 min postinjection or on thermal sensitivity to infrared red stimuli (B; Hargreaves test) measured at 7 hr postinjection.
(legend continued on next page)
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Wnt Signaling in Sensory Neurons and Painantibody (generously provided by Dr. David Julius, UCSF). Using
Trpv1/mice as a negative control, we observed that the com-
mercial antibody is not specific in immunohistochemistry exper-
iments on DRG sections (data not shown) but is specific in
immunocytochemistry experiments on cultured DRG neurons
and heterologously expressed TRPV1 (shown in Figures S4A
and S4B). Using either of the above antibodies, we observed
that after 90 min of Wnt3a exposure, cultured, mature DRG neu-
rons show an increased surface localization of TRPV1 in immu-
nocytochemical staining (an example is shown in Figure S4C).
Interestingly, DRG neurons that expressed Fzd3 endogenously
showed a prominent immunoreactivity for phosphorylated Src
after Wnt3a treatment and demonstrated TRPV1 localization at
the cell membrane as compared to a more intracellular distribu-
tion in non-Fzd3-expressing cells (Figure 4H). To test quantita-
tive changes in vivo, we ascertained that the specificity of the
noncommercial antibody in recognizing the approximate
100 kDa band specific to TRPV1 using DRGs from Trpv1/
mice as a control (an example is shown in Figure S4D). Impor-
tantly, in vivo, we observed an increase in the expression of
TRPV1 in the membrane fractions derived from L3-L4 DRGs of
Wnt3a-injected mice starting only at 4 hr post-Wnt3a injection,
and reaching significance only at 6 hr after Wnt injection
(example blot and quantitative summary from at least three
mice/group is shown in Figure 4I). Finally, upon establishing
pulldowns of TRPV1 from distal segments of the sciatic nerve,
we observed that an increased expression of TRPV1 in mice
receiving intraplantar Wnt3a injections as compared to
vehicle-injected mice, at 6 hr, but not at 3 hr, after Wnt3a
injection (Figure 4J), which is consistent with the time course
of Wnt3a-induced thermal hypersensitivity. This increase in
TRPV1 protein expression in the DRG and the sciatic nerve
was not reflected in a significant change in trpv1 mRNA in
Wnt3a-treated DRG neurons, indicating that this is not a tran-
scriptionally regulated process (quantitative RT-PCR data in
Figure S4E).
In behavioral experiments in vivo, we observed that peripheral
blockade of the noncanonical calcium pathway, e.g., using KN-
93 to block CaMKIIa and PP2 to block Src activity, led to a com-
plete loss of intraplantar Wnt3a-induced thermal hyperalgesia at
7 hr after Wnt3a injection (bottom panels in Figures 4K and 4L,
respectively). In contrast, blockade of neither CaMKIIa nor Src
signaling blocked intraplantar Wnt3a-induced mechanical
hypersensitivity, measured at 30min and 2 hr afterWnt3a admin-
istration (top panels in Figures 4K and 4L, respectively). In both
cases, inhibitors were given continuously over the entire period
up to the measurement of thermal hyperalgesia at 7 hr after
Wnt delivery.(C and D) Time-course analyses of the effects of a single intraplantar dose of 10 n
heat (D).
(E and F) Characterization of effects on mechanical (E) or thermal (F) hypersensitiv
of Dishevelled, NSC 668032 (20 ng given 30 min before and 6 hr after Wnt3a inje
dose 30 min prior to Wnt3a); vehicle or control IgG served as a negative controls
(G, H, and I) Electrophysiological analysis of effects of Wnt3a on activity of identi
activity in all recorded fibers upon 60 min exposure to diverse doses of Wnt3a or v
Wnt3a (I). y axis in (G) represents responses of mechanosensitive nociceptors t
microns on the x axis). *p < 0.05 as compared to corresponding vehicle contro
n = 5–7 mice/group. Data represent mean ± SEM. Also see Figure S1.These data indicate that the calcium arm of Wnt signaling,
comprising of calcium-Src-CamKII signaling, directly enhances
the membrane localization as well as the peripheral targeting
of TRPV1 over a time frame of several hours and thus mecha-
nistically accounts for the delayed onset of Wnt3a-mediated
thermal hyperalgesia; however, it does not play a role in
Wnt3a-induced mechanical hypersensitivity.
A Key Role for the Planar Cell Polarity Pathway of Wnt
Signaling in Peripheral Sensory Neurons
We then explored potential contributions of the planar cell po-
larity (PCP) arm of Wnt signaling (Figure 5A), in which a Wnt-
Fzd interaction brings about activation of Dishevelled-associ-
ated activator of morphogenesis 1 (DAAM1) to stimulate the
RhoGTPase RhoA and its downstream effector, RhoA-depen-
dent Kinase (ROCK) as well as the RhoGTPase Rac1 and its
downstream target, c-Jun amino (N)-terminal kinase (JNK);
both RhoA-ROCK and Rac-JNK pathways have diverse cellular
targets, including the cellular cytoskeleton (Figure 5A; Komiya
and Habas, 2008). Using G-ELISA assays on lysates of
neuron-enriched DRG cultures, we observed that exposure to
Wnt3a produced a robust activation of the Rac1 in sensory
neurons within 15 min (Figure 5B). Accordingly, we observed
enhanced JNK phosphorylation in L3-L4 DRGs of mice
receiving an intraplantar hindpaw injection of Wnt3a as
compared to vehicle-injected mice via immunohistochemistry
(typical examples and quantification in Figure 5C) as well as
via western blot analysis (examples and quantification in
Figure 5D).
In vivo behavioral analyses revealed a key role for some com-
ponents of the PCP pathway in Wnt3a-mediated mechanical
hypersensitivity. A neuron-specific knockdown of Rac1 in
L3/L4 DRGs using the AAV virions to express specific, previ-
ously validated shRNAs directed against Rac1 led to a loss of
Wnt3a-induced mechanical hypersensitivity but a preservation
of thermal hyperalgesia as compared to mice expressing
scrambled control RNA in the DRG (Figure 5E). Similar results
were obtained upon intraplantar pretreatment with an inhibitor
of Rac1 (NSC23766; Figure 5F). Furthermore, intraplantar pre-
treatment with a JNK blocker (SP600125) completely abro-
gated Wnt3a-induced mechanical hypersensitivity without
affecting Wnt3a-induced thermal hyperalgesia (Figure 5G). In
contrast, inhibition of ROCK via intraplantar Y-27632 neither
affected Wnt3a-induced mechanical hypersensitivity nor ther-
mal hyperalgesia (Figure 5H). These results suggest that the
Rac-JNK signaling arm of the PCP pathway, not the RhoA-
ROCK arm, contributes to Wnt3a-induced mechanical
hypersensitivity.g Wnt3a in the mouse hindpaw on sensitivity to graded von Frey stimuli (C) or
ity elicited by intraplantar Wnt3a (10 ng) by administration of a specific inhibitor
ction each) or of neutralizing antibodies against Fzd1 and Fzd3 (2.5 mg each; 1
, respectively.
fied Ad-mechanoreceptive fibers in a paw skin-nerve preparation (G); average
ehicle (H) and pie diagram revealing the percentage of fibers that responded to
o graded mechanical stimuli (represented as displacement of a nanometer in
l, two-way ANOVA for random measures followed by post hoc Fischer’s test;
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Translocation of TRPA1 and P2X3
Based on the above data as well as the observed acute nature of
Wnt3a-induced hypersensitivity, we hypothesized that the Wnt-
PCP pathway acting via Rac1-JNK leads to rapid modulation of
the molecular machinery involved in transducing mechanical
pressure in peripheral sensory nerves (Figure 6A). The precise
molecular composition of the assembly transducing mechanical
touch and pressure into membrane depolarization is not fully
clear. However, several mediators have been implicated in
mechanical sensitization in peripheral neurons, among which
we were interested in the ion channels TRPA1 and P2X3 (e.g.,
Tsuda et al., 2000; Petrus et al., 2007), sincewe found consensus
motifs for JNK phosphorylation in their intracellular segments. To
test whether Wnt3a can directly or indirectly modulate P2X3 and
TRPA1 channels functionally, we employed HEK293 cells heter-
ologously cotransfected with plasmids expressing Fzd3 and
either DsRed-tagged P2X3 or TRPA1-IRES-YFP and analyzed
calcium transients evoked by a first application of Allyl isothiocy-
nate (AITC; TRPA1 agonist) or a,b-methyleneATP (a,b-meATP,
P2X3 agonist) as a surrogate parameter for channel activation
(example in Figure 6B, top); subsequently, cells were washed
and exposed toWnt3a or vehicle followed by awashout and sec-
ond application of AITC or a,b-meATP at about 10 min after
Wnt3a/vehicle treatment (example in Figure 6B, middle). In
contrast to vehicle application, in cells treated with Wnt3a, the
second application of a,b-meATP led to calcium transients that
were significantly larger in magnitude than those evoked by the
first application of the agonist (quantitative summary in Figure 6B,
bottom). AITC-induced calcium transients showed a nonsignifi-
cant trend for increase within 10 min after Wnt3a application
(Figure 6B).
Apart from direct channel modulation, intracellular signaling
pathways can regulate ion channels by altering their intracel-
lular trafficking and cell-surface targeting. Indeed, in HEK293
cells coexpressing myc-tagged TRPA1 or myc-tagged P2X3
with Fzd3, within 30 min to 1 hr after exposure to Wnt3a, but
not vehicle, a marked increase was observed in anti-myc
immunoreactivity at the cell surface (Figure 6C). As another in-
dependent method of quantitative assessment of Wnt3a-Figure 3. Analysis of Activation of the Wnt Canonical Signaling Pathwa
Hypersensitivity
(A) Schematic representation of the canonical Wnt signaling pathway.
(B) RT-PCR analysis of Wnt3a-induced increase in the transcription of b-catenin t
vehicle (n = 5 mice per group).
(C) Example of Wnt3a-induced nuclear translocation of b-catenin in cultured DR
(D) Analysis of Wnt3a-induced b-catenin activation and downstream transcriptio
sentative examples of LacZ staining on sections of DRG from reporter transgenic m
a blocker of CaMKIIa (0.1 nmol; n = 3), or a combination of Wnt3a (10 ng) and K
function of total number of DRG neurons is given in the insets.
(E and F) No change in intraplantar Wnt3a-induced mechanical hypersensitivity
ceptor-specific manner (SNS-b-catenin/) as compared to their control littermat
neurons (Adv-b-catenin/) as compared to their control littermates (b-cateninfl/fl
(G and H) Effect of adult-onset neuron-specific deletion of b-catenin via injection
on intraplantar Wnt3a-induced mechanical hypersensitivity (G) and thermal hype
(I) Effect of specific blockade of b-catenin-dependent transcription with PNU-47
thermal hyperalgesia (left) or mechanical hypersensitivity (right) evoked by a sin
corresponding vehicle control, two-way ANOVA for random measures followed b
Data represent mean ± SEM. Also see Figures S1 and S2 and Tables S2, S3, aninduced membrane translocation of TRPA1 and P2X3, we per-
formed surface biotinylation experiments on HEK293 cells
transfected with Fzd3 and either myc-tagged TRPA1 or myc-
tagged P2X3. In contrast to vehicle, HEK293 cells exposed to
Wnt3a for 30 min showed a significantly higher content of
cell-surface biotin-labeled TRPA1 as well as biotin-labeled
P2X3 (Figure 6D).
Finally, blockade of peripheral P2X3 or TRPA1 via intraplantar
injection of A317491 or AP-18 partially, but significantly, blocked
mechanical hypersensitivity evoked by peripheral Wnt3a (Fig-
ure 6E), while preserving Wnt3a-induced thermal hyperalgesia
(Figure S5). Furthermore, intraplantar Wnt3a failed to induce
mechanical hypersensitivity in mice genetically lacking TRPA1
(Figure 6E). Thus, the PCP pathway acting via Rac1-JNK
enhances the membrane targeting of P2X3 or TRPA1 in sensory
neurons and can thus account for Wnt3a-induced mechanical
hypersensitivity.
Expression Profiles of Mediators of Mechanical versus
Thermal Modalities of Wnt3a-Induced Nociceptive
Hypersensitivity
Because multiple Fzds show a broad expression over the DRG
(Figure 1; Figure S1) and their immediate interaction partners,
such as b-catenin, Dishevelled, and G proteins, show ubiquitous
expression, we tested the hypothesis that cell-type-specific
recruitment of downstream mediators comprising the calcium-
Src pathway and PCP-JNK pathway imparts specificity to
mechanical and thermal modalities. In immunohistochemistry
experiments, we observed that IB4-positive nonpeptidergic no-
ciceptors and NF-200-positive myelinated mechanoreceptive
neurons accounted for 86% of neurons showing JNK phosphor-
ylation (Figure S6), indicating a preferential activation of the
PCP JNK-Rac pathway in DRG neuron types associated with
mechanical hypersensitivity (Cavanaugh et al., 2009). In
contrast, CGRP-positive peptidergic nociceptors, which have
been associated with thermal hyperalgesia (Cavanaugh et al.,
2009), accounted for about 60% of all DRG neurons showing
Wnt3a-induced Src phosphorylation, whereas IB4-positive neu-
rons only accounted for 19% of pSrc-positive neurons
(Figure S6).y in DRG Neurons and Its Contribution to Wnt-Induced Nociceptive
argets in L3-L4 DRG of mice 6 hr after intraplantar injection of Wnt3a (10 ng) or
G neurons (n = 3 independent culture experiments).
n of b-galactosidase in the DRG of BAT-Gal reporter mice. Shown are repre-
ice injected intraplantar with vehicle (n = 3), Wnt3a (10 ng; n = 5), KN-93 alone,
N-93 (0.1 nmol; n = 5) in the hindpaw. Fraction of LacZ-positive neurons as a
(E) or thermal hyperalgesia (F) in mice genetically lacking b-catenin in a noci-
es (b-cateninfl/fl) (n = 10 mice/genotype) or in mice lacking b-catenin in all DRG
) (n = 8 mice/genotype).
of AAV-Cre (or AAV-GFP as control) into L3-L4 DRGs of adult b-cateninfl/fl mice
ralgesia (H) (n = 8 mice/group).
654 (PNU, 2 nmol given 30 min before and 6 hr after Wnt3a injection each) on
gle intraplantar hindpaw injection of Wnt3a (10 ng). *p < 0.05 as compared to
y post hoc Fischer’s test. Scale bars represent 20 mm in (C) and 50 mm in (D).
d S4.
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Wnt Signaling in Sensory Neurons and PainContribution of Wnt3a-Regulated Genes to Subacute
to Long-Term Nociceptive Modulation
Wnt signaling can also modulate gene transcription, not only
directly via the canonical b-catenin pathway, but also further
downstream of noncanonical pathways, such as the calcium
signaling pathway. Upon performing a genome-wide transcrip-
tome analysis on neuron-enriched DRG cultures treated with
Wnt3a or vehicle for 6 hr, 151 genes were observed to be signifi-
cantly up- or downregulated in Wnt3a-treated neurons as
compared to vehicle-treated neurons (Table S2). These included
several genes that have been described in relation to Wnt
signaling in other systems or context (Table S3), as well as genes
encodingsome targets linked topainmodulation previously, such
as the chemokine receptor CXCR4 (Cxcr4), the receptor tyrosine
kinase TrkB (Ntrk2), and the proton-gated ion channel Asic3
(Accn3). Wnt3a-induced upregulation of Cxcr4 and Ntrk2, but
not of Accn3, could be confirmed via quantitative real-time PCR
analysis on cDNAs from cultured DRG neurons and further vali-
dated in DRG samples obtained frommice injected intraplantarly
with Wnt3a (Figure S7A). Gene ontology analysis also suggested
a role forWnt3a in regulating expression of some knownmodula-
tors of nerve activity and synaptic transmission (Table S4).
Furthermore, blocking TrkB via ANA-12 injected intraplantarly
three times over 24 hr significantly together with Wnt3a
attenuated the thermal as well as mechanical hypersensitivity
measured at 24 hr (Figures S7B and S7C). In contrast, blockade
of CXCR4 via AMD3100 only attenuated mechanical, but not
thermal, hypersensitivity evoked by a 24 hr treatment with
Wnt3a (Figures S7B and S7C). These results indicate that
Wnt3a-regulated genes can indeed contribute to a subacute
modulation of nociception, particularly in pathological states
associated with prolonged, high levels of Wnt signals.
Contribution and Translational Potential for Peripheral
Wnt Signaling in Disease-Related Pain Hypersensitivity
We then sought to test the biological significance of the above
findings in a pathophysiological context involving high peripheralFigure 4. Analysis of the Wnt Noncanonical Calcium Signaling Pathw
Hypersensitivity
(A) Schematic representation of the Wnt noncanonical calcium signaling pathwa
(B) Typical examples and quantitative representation of ratiometric Fura2 imaging
(200 ng/ml) in comparison to vehicle application in dissociated DRG neurons ke
observed immediately as well as 3–5 min after Wnt3a/vehicle application are sum
including measures taken to rule out mechanical artifacts.
(C) ELISA-based analysis of release of inflammatory cytokines from cultured mo
(D, E, and F) Analysis of phosphorylation of CaMKIIa (pCaMKIIa) in L3-L4 DRG
immunofluorescence on DRG sections (D) or quantitative western blot analysis
represent measurements of intensity of pCaMKIIa signals normalized to b-tubuli
densitometric quantification of pCaMKIIa signals normalized to corresponding G
(G) Western blot analysis of Src-kinase and phosphorylation of Src (pSrc) in L3-L4
Wnt3a (10 ng) in combinationwith a function-blocking antibody against Fzd3 (4 mg
corresponding GAPDH signals (loading control) from five independent blots are
(H) Example of immunofluorescence on cultured DRG neurons treated with Wnt3a
neurons expressing Fzd3 receptor and activated Src kinase.
(I and J) Examples and densitometric quantifications of western blot analysis of TR
after intraplantar injection of vehicle or Wnt3a (10 ng) at different time points ind
(K and L) Effects of blockade of CaMKIIa (KN-93; 0.1 nmol given 30min prior toWn
mice/group) in vivo via intraplantar injection on mechanical hypersensitivity (top
injection of Wnt3a (10 ng) in comparison to vehicle. In all panels, *p < 0.05 as com
Fisher’s test. Scale bars represent 50 mm in (C). Data represent mean ± SEM. Allevels of Wnt ligands. Misregulation of Wnt signaling has been
causally linked to tumorigenesis, metastasis, osteoporosis,
and inflammatory disorders (Fodde and Brabletz, 2007; Mac-
Donald et al., 2009). RT-PCR analysis revealed the expression
of Wnt5a, but not of Wnt3a, in the DRGs of naive mice (Figures
S8A and S8B), which was confirmed in western blot analysis,
using previously characterized antibodies recognizing Wnt
ligands (Alfaro et al., 2008) (Figures 7A and 7B; specificity control
in Figure S8C). The molecular weights of native Wnt5a and
Wnt3a were somewhat smaller than those of recombinant
Wnt5a andWnt3a, which may reflect differences in glycosylation
patterns (Komekado et al., 2007) (Figures 7A and 7B). Wnt3a
protein was neither detected in the DRG lysates nor in
paw skin lysates derived from wild-type naive mice (Fig-
ure 7B). In contrast to vehicle-injected mice, mice injected with
fibrosarcoma cells into the calcaneous bone of the heel to simu-
late bone metastases (Cain et al., 2001) or mice injected intra-
plantarly with complete Freund’s adjuvant (CFA) (Hartmann
et al., 2004) to induce paw inflammation showed Wnt3a expres-
sion in paw lysates, but not in DRG lysates (Figure 7B;
Figure S8C); in contrast, Wnt5a expression was evident in
DRG lysates, but not in paw lysates, derived from control mice
as well as tumor-bearing or inflamed mice (Figure 7A). Thus, tu-
mor growth, and paw inflammation to a lesser extent, is associ-
ated with a peripheral availability of Wnt3a in mice.
To test the translational significance of these findings, we
studied mechanical hypersensitivity, which develops after
implantation of osteolytic fibrosarcoma cells into the calcaneous
bone cavity in wild-typemice of the C3H strain (Cain et al., 2001).
In this model, we administered soluble Fzd-binding proteins 2
and 3 (sFRPs), which dose dependently bind and sequester all
Wnt family ligands (Kawano and Kypta, 2003), or bovine serum
albumin (BSA) as a control protein, in the vicinity of the calcane-
ous bone. In sFRP-treated mice, tumor-induced mechanical
hypersensitivity to normally innocuous stimuli, e.g., 0.07 g and
0.16 g, was markedly reduced as compared to BSA-injected
mice (Figure 7D). To determine which source of Wnt mediatesay in DRG Neurons and Contribution to Wnt-Induced Nociceptive
y.
of rapid and delayed calcium transients evoked upon acute exposure toWnt3a
pt in culture for 16–24 hr in the absence of exogenous growth factors; effects
marized in the bottom panel; n = 185 neurons over 7 independent experiments,
use DRG neurons upon Wnt3a application (100 ng/ml 3min) or vehicle.
s of mice with intraplantar hindpaw injection of Wnt3a (10 ng) or vehicle via
(E and F). The numbers on the left side of immunofluorescence panels in (D)
n signal intensity in the same section (n = 3 mice/group). Panel (F) represents
APDH signals (loading control) from four independent blots.
DRGs of mice with intraplantar hindpaw injection of vehicle or Wnt3a (10 ng) or
). Densitometric quantifications of pSrc signals or total Src signals normalized to
shown in the bottom panels.
(100 ng/ml) showing a stronger membrane localization of TRPV1 signal only in
PV1 signal inmembrane preparation of L3-L4 DRGs (I) or sciatic nerve tissue (J)
icated.
t3a; J; n = 5mice/group) or Src (PP2; 20 ng given 30min prior toWnt3a; K; n = 6
) and thermal hyperalgesia (bottom) evoked by a single intraplantar hindpaw
pared to vehicle, two-way ANOVA for random measures followed by post hoc
so see Figures S3, S4, and S6.
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Figure 5. Analysis of Activation of Wnt Noncanonical Planar Cell Polarity Signaling Pathway in DRG Neurons and Its Contribution to
Wnt3a-Induced Nociceptive Hypersensitivity
(A) Schematic representation of the Wnt noncanonical PCP pathway.
(B) ELISA-based analysis of Rac1 activation in cultured mouse DRG neurons upon exposure to Wnt3a (200 ng/ml; n = 4 independent culture experiments).
(C) Analysis of phosphorylation of JNK (pJNK) by immunofluorescence in L3-L4 DRGs of mice with intraplantar hindpaw injection of Wnt3a (10 ng) or vehicle (left).
Right: measurements of intensity of pJNK signals normalized to b-tubulin signal intensity in the same section (n = 3 mice/group).
(legend continued on next page)
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Wnt Signaling in Sensory Neurons and Painthis sensitization in the tumor-pain model in vivo, we adminis-
tered specific neutralizing antibodies against Wnt3a or Wnt5a
or the control IgG in the vicinity of the calcaneous bone over
the entire course of tumor growth. Consistent with our expres-
sion data (Figures 7A and 7B), we observed that a Wnt3a-
neutralizing antibody, but not a Wnt5a-neutralizing antibody or
IgG, significantly attenuated tumor-induced mechanical hyper-
sensitivity (Figure 7D).
We then injected mice intraplantarly with a combination of
anti-Fzd1 and anti-Fzd3 blocking antibodies (0.2 mg/ml each
injected in 25 ml volume) or the corresponding IgG control in
the vicinity of the tumor on days 0, 1, 3, 5, and 7 after implanta-
tion of tumor cells (Figure 7E). Tumor-bearing mice injected with
anti-Fzd1/3 antibodies developed a significantly lower magni-
tude of tumor-associated hypersensitivity to graded mechanical
stimuli than tumor-bearing mice injected with control IgG (Fig-
ure 7E). To further address mechanisms, we utilized TRPA1/
mice, which necessitated employing a model with tumor cells
isogenic to the background of the knockout mice, namely lung
carcinoma cells (LL2) injected in the paw (Sto¨sser et al., 2010).
Tumor-induced mechanical hypersensitivity to mild (0.07 g or
0.16 g) as well as noxious mechanical forces was significantly
reduced in TRPA1/ mice (Figure 7F), indicating a contribution
of TRPA1 toward tumor-associated pain. Blockade of P2X3,
the other Wnt3a target found in our study, has been already
reported to alleviate cancer-associated hypersensitivity (Kaan
et al., 2010).
Specific Functional Contribution of Fzd3 Expressed
in Sensory Neurons toward Tumor-Associated Pain
Hypersensitivity
Because the above tools could have potentially affected tumor
cells or immune cells in the tumor milieu rather than selectively
affecting sensory nerves, we employed lentivirions expressing
shRNA against Fzd3 to directly and specifically manipulate
Fzd3 signaling in the DRG, which we have previously described
(Schweizerhof et al., 2009) (Figure 8A). At 3 weeks after intra-
DRG lentiviral injection, marked knockdown of Fzd3 was
observed in the L3-L4 DRGs of the Fzd3 shRNA group as
compared to the scrambled shRNA group in western blot
analysis (Figure 8B) and immunohistochemistry (Figure S8D).
Mechanical hypersensitivity evoked by a single intraplantar
injection of Wnt3a was strongly and significantly attenuated in
mice expressing lentiviral Fzd3 shRNA, but not in mice express-
ing scrambled shRNA, thereby demonstrating efficacy of Fzd3
knockdown (Figure 8C). Because lentiviral knockdown of Fzd3
may have affected neuronal and nonneuronal cells in the DRG,
we also utilized AAV serotypes that yield broad and neuron-
specific expression (Figure 8D; absence of colocalization of(D) Western blot analysis of phosphorylation of JNK in L3-L4 DRGs of mice w
quantification of pJNK signals normalized to corresponding GAPDH signals (load
(E) Effects of neuron-specific knockdown of Rac1 in L3-L3 DRGs by short-hairpin
virions expressing Rac1-specific shRNA or scrambled shRNA (control) on mecha
intraplantar hindpaw injection of Wnt3a (10 ng) in comparison to vehicle.
(F, G, and H) Effects of intraplantar injection of specific inhibitors of Rac1 (NSC237
27632; 25 mg; H), each given 30 min before and 6 hr after Wnt3a injection, on me
single intraplantar hindpaw injection of Wnt3a (10 ng) in comparison to vehicle; n =
way ANOVA for random measures followed by post hoc Fisher’s test. Scale barsAAV-GFP with markers for blood vessels, satellite cells, and
Schwann cells in DRG) to induce a neuron-specific knockdown
of Fzd3 via expression of shRNA (AAV-Fzd3 shRNA; AAV-scram-
bled shRNAwas used as a control). The efficiency of knockdown
was verified via western blotting (Figure 8E) as well as immuno-
histochemistry for Fzd3 (Figure S8E). Behavioral analyses of
Wnt3a-induced acute nociceptive hypersensitivity revealed a
qualitatively similar phenotype in mice AAV-induced knockdown
of Fzd3 as observed in mice with lentivirally induced knockdown
of Fzd3 and (Figure 8F; Figure S8D), themagnitude of the pheno-
type being larger in AAV-treated than in lentivirus-treated mice,
since a broader set of neurons were affected. Importantly, the
neuron-specific nature of this manipulation ruled out con-
tributions of nonneuronal cells to phenotypic alterations.
Finally, the progressive development of tumor-associated
mechanical hypersensitivity was markedly attenuated in mice
injected with AAV-Fzd3 shRNA or lentiviral Fzd3 shRNA, but
not in control mice injected with AAV scrambled shRNA or lenti-
viral scrambled shRNA (Figures 8G and 8H; Figures S8F and
S8G). Importantly, differences in mechanical hypersensitivity in
all of the above groups did not come about owing to major differ-
ences in tumor growth per se; gross histopathological analyses
of tumor size did not reveal significant differences in the groups
tested (Figure 8I).
DISCUSSION
The recent years have witnessed a remarkable extension of the
focus on Wnt signaling from its role in development to disease
in adult life. For example, Wnt pathway functions in neural cir-
cuit development are now providing a basis for developing
therapeutic approaches for nerve regeneration and circuit
repair after injury or disease (MacDonald et al., 2009; Budnik
and Salinas 2011). The present study now provides evidence
that components of this developmentally active system are re-
tained in adult dorsal root ganglia and play a key role in modu-
lating sensitivity of peripheral axons to mechanical and thermal
sensory stimuli.
In the Wnt signaling system, the rich diversity of Wnt ligands is
mirrored by an intriguing complexity of receptors, coreceptors,
and signaling effectors. Here, we focused on Fzd3 and Fzd1 as
key receptors on sensory nerves on the basis of our expression
analyses as well as observations that blocking Fzd1 and Fzd3
function or knocking down the expression of Fzd3 alone
specifically in DRG neurons nearly abrogated Wnt-induced
hypersensitivity. Whereas Wnt5a was found to be expressed in
the DRG and may thus function in an autocrine manner, Wnt3a
emerged as a ligand that is abundant in peripheral tissues in a
pathological context only, such as upon inflammation orith intraplantar hindpaw injection of vehicle or Wnt3a (10 ng). Densitometric
ing control) from three independent blots is shown.
RNAs (shRNAs) transduced via in vivo DRG injection of recombinant AAV1/2
nical hypersensitivity (left) and thermal hyperalgesia (right) evoked by a single
66; 20 mg; F) or JNK (SP600125, 5 mg; G) or RhoA-dependent Kinase (ROCK)(Y-
chanical hypersensitivity (top) and thermal hyperalgesia (bottom) evoked by a
6mice/group in all panels. In all panels, *p < 0.05 as compared to vehicle, two-
represent 50 mm in (D). Data represent mean ± SEM. See also Figure S6.
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A
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D
E
F
C Figure 7. Attenuation of Disease-Associ-
ated Pain Hypersensitivity by Pharmacolog-
ical Intervention in Peripheral Wnt Signaling
(A and B) Expression of Wnt5a (A) or Wnt3a (B) in
lysates from hindpaws or DRGs of mice injected
intraplantar with vehicle (PBS), complete Freund’s
adjuvant (CFA), or osteolytic fibrosarcoma cells in
the calcaneous bone (cancer). Positive control:
recombinant mouse Wnt3a or Wnt5a; loading
control: b-tubulin or GAPDH. Numbers in (B)
represent densitometric quantification (arbitrary
units) of Wnt3a signals normalized to corre-
sponding b-TubIII signals (loading control) from
three independent blots.
(C) In the same model, effects of injections of
neutralizing antibodies against Wnt3a, Wnt5a or
control IgG (4 mg each) in the tumor vicinity on days
1, 3, 5, 7, and 9 on tumor-induced mechanical
hypersensitivity; n = 8 mice/group.
(D) In the same model, effects of injection of a mix
of soluble Frizzled Binding Proteins 2 and 3
(sFRPs, 100 mg total) or of BSA (100 mg; control) in
the tumor vicinity on days 1, 3, 5, and 7 signifi-
cantly on mechanical hypersensitivity. Left:
responses to graded mechanical von Frey stimuli
on day 8 after tumor cell implantation. Integral of
response frequency-von Frey stimulus intensity
curves over the temporal course of tumor pro-
gression are shown on the right.
(E) Effects of injection of anti-Fzd1 and anti-Fzd3
function blocking antibodies (4 mg each) or control
IgG injections (8 mg) in the tumor vicinity on days 1,
3, 5, and 7 after tumor cell implantation on hyper-
sensitivity to graded mechanical von Frey hairs on
day 6 posttumor implantation (left) or over the
course of tumor progression (right).
(F) Behavioral analysis of mechanical hypersensi-
tivity in a cancer pain model based on hindpaw
subcutaneous injection of isogenic lung carci-
noma cells in TRPA1/ mice and wild-type mice
prior to (basal, unfilled symbols) and on day 4 after
tumor cell implantation (filled symbols). Integral of
response frequency-von Frey stimulus intensity
curves over the course of tumor progression are
shown on the right. In all panels, n = 7–10 mice/
group; *p < 0.05 as compared to baseline values
and yp < 0.05 as compared to the corresponding
control group (i.e., wild-type mice, IgG or BSA in-
jection); two-way ANOVA followed by post hoc
Fischer’s test. Data represent mean ± SEM. See
also Figure S8.
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Wnt Signaling in Sensory Neurons and Paintumor growth, thereby possessing the capacity for paracrine
modulation of neighboring nociceptive nerves and eliciting pain
hypersensitivity.(C) Wnt3a-induced changes in subcellular localization of myc-tagged TRPA1 or m
confocal images, and quantification of fluorescence intensity at the cell membra
(D) Surface biotinylation assays addressing surface expression of TRPA1 or P2X
examples of surface-labeled (biotinylated) TRPA1 or P2X3 and their correspondin
treated cells over vehicle-treated cells of the ratio of biotinylated to total protein
(E) Effects of blockade of P2X3 (A317491, 100 mg; Sigma) or TRPA1 (AP-18, 20 nm
injection onmechanical hypersensitivity evoked by a single intraplantar hindpaw i
and vehicle groups each, n = 7 mice for AP-18 and vehicle groups each). Wnt3a-in
to their wild-type controls (B6.129PF-2/j strain) (panel at the far right; n = 4–6 mic
random measures followed by post hoc Fisher’s test. Data represent mean ± SEInterestingly downstreamof Fzd3/Fzd1, we found evidence for
an intriguing dichotomy of noncanonical signaling pathways in
mediating mechanical and thermal hypersensitivity. Recentyc-tagged P2X3 in HEK293 cells. Shown are typical examples, line profiles on
ne relative to cytoplasmic localization (n = 40–45 cells/group).
3 in HEK293 cells exposed to vehicle or Wnt3a (200 ng/ml). Shown are typical
g total input levels (top) and quantification of percentage of increase in Wnt3a-
(n = 4 and 3 independent experiments for TRPA1 and P2X3, respectively).
ol; Sigma), each given 30 min prior to Wnt3a injection, in vivo via intraplantar
njection of Wnt3a (10 ng/20 ml) in comparison to vehicle (n = 6 mice for A317491
duced mechanical hypersensitivity is abrogated in TRPA1/mice, in contrast
e/group). In all panels, *p < 0.05 as compared to vehicle, two-way ANOVA for
M. See also Figure S5.
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Wnt Signaling in Sensory Neurons and Painadvances in understanding Wnt signaling indicate that the same
Wnt ligand can activate different signaling pathways depending
on the regional and situational context and recent findings show
that the receptor context and availability, not the ligand, dic-
tates the Wnt signaling output (Mikels and Nusse, 2006). As
such, the PCP pathway acting via Rac-mediated JNK activa-
tion, which has so far been primarily associated with Wnt-
induced cytoskeletal regulation and thereby in structural modu-
lation in developing central neurons (Budnik and Salinas 2011),
was found to be critical for Wnt-induced peripheral mechanical
hypersensitivity.
In contrast, diverse cellular assays and in vivo pharmacolog-
ical and genetic analyses indicate that Wnt3a-induced thermal
hypersensitivity is largely mediated by the noncanonical calcium
pathway acting via CaMKIIa and Src. Indeed, Src-mediated traf-
ficking of the heat- and proton-sensitive cation channel, TRPV1,
from cytoplasmic pools to the cell membrane has been reported
to thermal hyperalgesia in response to other sensitizing mole-
cules, including the nerve growth factor (Zhang et al., 2005;
Basbaum et al., 2009). Here, we observed that Wnt3a-induced
enhanced Src activity is associated with TRPV1 targeting to
membrane and terminal compartments of sensory neurons,
which requires several hours to unfold, explaining thereby the
delayed onset of Wnt3a-induced thermal hyperalgesia.
Our results indicate that the dichotomy of pathways mediating
thermal and mechanical hypersensitivity is linked to the type of
sensory neurons they are recruited in following Wnt3a-mediated
Fzd activation. In particular, the IB4-binding nociceptors, which
have been associated with mechanical nociception by Cava-
naugh et al. (2009), and NF-200 positive, which are mechano-
sensitive populations, showed a dominant recruitment of the
Rac-JNK PCP pathway, whereas peptidergic nociceptors,
which have been linked to thermal nociception and largely
account for the restricted adult expression pattern of TRPV1
(Cavanaugh et al., 2009), showed a preferential recruitment of
the Src-TRPV1 signaling pathway. Coupling between Fzds and
their signalingmediators occurs in specificmicrodomains, which
can be distinct between different types of sensory neurons, and
can thus explain how different pathways can bring about modu-
lation of specific modalities despite the sameWnt-Fzd receptors
being activated across all neurons.Figure 8. Evidence for a Functional Role for Neuronally Expressed Fzd
(A) Evidence for lentiviral gene delivery (here, GFP) to sensory neurons following
(B) Evidence for marked knockdown of Fzd3 expression upon injection of lentivi
DRG via western blot analysis using b-Tubulin-III expression as a control; densitom
(C) Significant, but partial, blockade of Wnt3a-induced mechanical hypersensitiv
injected with lentiviral scrambled shRNA (n = 6 mice/group).
(D) Evidence of neuron-specific AAV1/2-gene delivery (here, GFP) following inject
nonneuronal cells in the DRG (CD31 for blood vessels, a-Schwann for Schwann
(E) Evidence for marked knockdown of Fzd3 expression upon injection of AAV-Fz
the DRG via western blot analysis using b-Tubulin-III expression as a control.
the bottom.
(F) Complete blockade of Wnt3a-induced mechanical hypersensitivity in mice
AAV-scrambled shRNA virions in the DRG (n = 7 mice/group).
(G and H) Mice injected with AAV-Fzd3 shRNA virions (G; n = 8 mice) or lentiviral
hypersensitivity to a markedly lower magnitude than mice injected with AAV-sc
*p < 0.05 as compared to corresponding control, two-way ANOVA followed by p
(I) Analysis of tumor area (represented as a fraction of total paw area) did not revea
mean ± SEM. See also Figure S8 and Table S5.The canonical arm of Wnt signaling has been reported to play
significant roles over the early stages of DRG development
(Patapoutian and Reichardt, 2000). A report published while
this study was under review demonstrated that Wnt signaling
via the canonical b-catenin pathway in the spinal cord plays a
role in neuropathic pain via modulation of NMDA receptors and
cytokine release (Zhang et al., 2013). Surprisingly, however,
our extensive analysis with pharmacological inhibitors as well
as highly specific genetic and shRNA tools did not indicate any
functional evidence for the canonical Wnt-signaling pathway in
Wnt3a-induced sensitization of peripheral neurons in an acute
to subacute context; this was entirely consistent with the small
number of DRG neurons showing nuclear translocation
of b-catenin in vitro or b-catenin-dependent b-galactosidase
induction in highly sensitive reporter mice in vivo as well as the
low magnitude of fold regulation of b-catenin-dependent genes
in profiling experiments. However, our data do not rule out a
role for b-catenin signaling in sensory neurons in a different
context, e.g., during regeneration and repair.
Finally, our observations ona sensitizing role for peripheralWnt
signaling and the detailed characterization of neurobiological
mechanisms thereof in adult DRG sensory neurons were further
consolidated in vivo and placed in translational context, namely
in cell-cell communication between adult sensory nerves and
tumor cells in cancer states, which constitutes a hallmark mech-
anistic feature of cancer-associated pain. Given that a DRG-spe-
cific knockdown of Fzd3 attenuated tumor-induced mechanical
hypersensitivity, using either lentivirions or AAV virions, which
enable select knockdown in neurons without affecting Schwann
cells, satellite cells, and blood vessels, to the same extent as
peripheral inhibition of Fzd1/3 or sequestration of Wnt ligands
in the paw, we conclude that Fzd-mediated signaling specifically
in sensory neurons plays a key role. Moreover, the finding that
sequestering Wnt3a peripherally in the tumor milieu via neutral-
izing antibodies or soluble Fzds is effective in alleviating tumor-
associated mechanical allodynia highlights the translational
value of Wnt-Fzd interactions in chronic pain.
In summary, this study places the classical, developmentally
critical Wnt signaling system as a key player in the modulation
of sensitivity of adult sensory neurons and their peripheral axons.
We infer that this peripheral role for Wnt signaling involves an3 in the DRG in Cancer-Associated Pain Hypersensitivity
injections into L3-L4 DRGs in mice in vivo.
ral-Fzd3 shRNA as compared to injection of lentiviral scrambled shRNA in the
etric quantification of three independent experiments is shown on the bottom.
ity in mice with DRG injections of lentiviral Fzd3 shRNA as compared to mice
ions into L3-L4 DRGs, shown by the lack of GFP colocalization with markers of
cells, GFAP for satellite cells).
d3 shRNA virions as compared to injection of AAV-scrambled shRNA virions in
Densitometric quantification of three independent experiments is shown on
injected with AAV-Fzd3 shRNA virions as compared to mice injected with
Fzd3 shRNA (H; n = 9 mice) in the DRG develop tumor-associated mechanical
rambled shRNA (G; n = 8 mice) lentiviral-scrambled shRNA (H; n = 7 mice);
ost hoc Fischer’s test.
l significant differences in tumor growth between groups tested. Data represent
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Wnt Signaling in Sensory Neurons and Paininterplay between diverse noncanonical Wnt signaling media-
tors, which, in turn, impact on classical transducers and ampli-
fiers of sensory stimuli. Finally, this study provides evidence for
a translational potential for targeting peripheral Wnt signaling in
tumor-nerve interactions and pathological pain hypersensitivity,
paving the way for therapeutic interventions.
EXPERIMENTAL PROCEDURES
Wild-Type and Transgenic Mice
Nociceptor- or DRG-specific knockout mutants for b-catenin were generated
by mating homozygous C57BL/6J mice carrying the floxed alleles for the
mouse Ctnnb1 locus encoding b-catenin (b-cateninfl/fl) mice (Huelsken et al.,
2001) and either SNS-Cre mice (Agarwal et al., 2004) or Advillin-Cre mice
(Zurborg et al., 2011). Details on the above as well as on transgenic mouse
lines that have been previously reported are described under the Supple-
mental Experimental Procedures online materials.
Behavioral Measurements and Transgenic Mice
All animal usage procedures were in accordance with ethical guidelines laid
down by the local governing body (Regierungspra¨sidium Karlsruhe). All
behavioral measurements were done in awake, unrestrained, age-matched
adult (more than 2months old) mice. Mice were habituated to the experimental
setup in at least two separate sessions within the week preceding the time of
behavioral testing. The observer was fully blinded to the identity of the groups
in all behavioral tests. See Supplemental Experimental Procedures for details
on behavioral tests.
Mouse Models of Tumor-Associated Pain
The bone metastases-pain model as well as the cancer pain model associated
with subcutaneous injection of LL2 cells were employed as described
previously (Cain et al., 2001; Sto¨sser et al., 2010). See Supplemental Experi-
mental Procedures for details.
Antibodies
The following antibodies were used in this study.
For immunohistochemistry, the antibodies used were anti-Fzd1 (1:100 R&D
Systems); anti-Fzd3 (1:400 R&D Systems); anti-phospho-CaMKIIa (1:500;
Promega); anti-phospho-Src (1:50; Cell Signaling); anti-phospho-JNK (1:100;
Cell Signaling); anti-b-Tubulin III antibody (1:1,000, Sigma); anti-CGRP
antibody (1:2,000; Immunostar); anti-NF200 antibody (1:300, Sigma); anti-
PGP9.5 antibody (1:500, rabbit polyclonal antibody RA95101; Ultraclone);
anti-CD31 antibody (1:200 BD); anti-Schwann antibody (1:10,000, Cosmo
Bio); anti-GFAP antibody (1:1,000, Sigma).
For immunofluorescence on cultured cells, the antibodies used were anti-
phospho-CaMKIIa (1:500 Promega), anti-phospho-Src (1:50; Cell Signaling),
anti-phospho-JNK (mouse anti-pJNK 1:200; Cell Signaling or Rabbit anti
pJNK 1:100 Cell Signaling), anti-Fzd3 (1: 400; rat monoclonal R&D Systems),
anti-Fzd1 (1:200; R&D System), anti-TRPV1 (1:500 Santa Cruz P-19), anti-
b-catenin (1: 50; BD), anti-b-tubulin III (1:1,000; T2200 Sigma) and secondary
antibodies conjugated with Alexa 488 or Alexa 594 (Molecular Probes,
Invitrogen), anti-myc antibody (1:500; Origene), and anti-Fzd3 (1:400; rat
monoclonal, R&D Systems).
For western blotting, the antibodies used were anti-phospho-CaMKIIa
(1:700 Promega), anti-phospho-Src (1:1,000; Cell Signaling), anti-phospho-
JNK (1:1,000; Cell Signaling), anti-Src (1:700; Cell Signaling), anti-Wnt3a
(1:700; R&DSystem), anti-Wnt5a (biotinylated antibody 1:1,000; R&D System),
anti-b-tubulin (1:6,000, T2200, Sigma Aldrich), anti-GAPDH (1:500; Santa
Cruz, an anti-TRPV1 antibody (goat P-19 1:500, Santa Cruz), or with an
anti-TRPV1 antibody kindly provided by D. Julius (UCSF).
For lentiviral or AAV virions injection into the DRG, the antibodies used were
AAV-Fzd3-shRNA-GFP (VectorBiolabs) or control AAV-shRNA scramble GFP
plasmid and AAV-Rac1 shRNA (IBA), AAV-CRE or AAV-GFP plasmid were
used to produce AAV-virions. Lentiviral or AAV injections into the DRGs in vivo
were performed as described in details previously (Schweizerhof et al., 2009).120 Neuron 83, 104–121, July 2, 2014 ª2014 Elsevier Inc.Gene Profiling
DRG cultures were serum starved for 1 hr and then treated withWnt3a (200 ng/
ml) or vehicle (PBS) for 6 hr. Total RNA was extracted with Trizol (Life Technol-
ogies) followed by clean-up and DNase I treatment with QIAGEN RNeasy mini
kit in accordance with the prescribed protocol provided with the kit. RNA
quality control was performed with Agilent Bioanalyzer. Microarray profiling
was performed at the Genomics and Proteomics Core Facility of the German
Cancer Research Center (DKFZ) using Illumina Sentrix expression BeadChips
(mouseRef-8 v2) according to the manufacturer’s recommendations. The
microarray data were deposited in the GEO database (http://www.ncbi.nlm.
nih.gov/geo/) under accession number GSE56880. See Supplemental
Experimental Procedures for details.
Statistics
All data are expressed as mean ± SEM. Two-way ANOVA followed by post
hoc Fisher’s tests were used to assess statistical significance. Changes with
p < 0.05 were considered to be significant.
Additional methods are described under Supplemental Experimental
Procedures.
ACCESSION NUMBERS
The GEO accession number for the microarray data reported in this paper is
GSE56880.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, and five tables and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.05.037.
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